 Beginning 30 minutes to 2 hours before radiation therapy, patients receive ropidoxuridine PO once daily QD on days 1-28 in the absence of disease progression or unacceptable toxicity. Beginning on day 8, patients undergo IMRT 5 days a week for 3 weeks in the absence of disease progression or unacceptable toxicity. 